ConductScience.org, home

Paper38931908

Exploring the Potential Use of Natural Products Together with Alkalization in Cancer Therapy.

Isowa M and 5 others. Pharmaceutics, 2024. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Exploring the Potential Use of Natural Products Together with Alkalization in Cancer Therapy. Papers, record 38931908. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/38931908

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Exploring the Potential Use of Natural Products Together with Alkalization in Cancer Therapy.
PubMed
Journal
Pharmaceutics
PubMed
Year
2024
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0.0, provisional
iCite
Revised in PubMed
2024-06-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Isowa MMasahidehttps://orcid.org/0000-0002-4210-1884
2Hamaguchi RReohttps://orcid.org/0000-0001-5877-0372
3Narui RRyoko
4Morikawa HHiromasahttps://orcid.org/0000-0002-6793-5885
5Okamoto TToshihiro
6Wada HHiromi

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
118623084Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials.Int J Cancer2008https://conductscience.org/library/papers/18623084PubMed
233347611Revisiting the Warburg effect: historical dogma versus current understanding.J Physiol2021https://conductscience.org/library/papers/33347611PubMed
318092339Bioactive food components and cancer risk reduction.J Cell Biochem2008https://conductscience.org/library/papers/18092339PubMed
427262332Phytochemicals as Adjunctive with Conventional Anticancer Therapies.Curr Pharm Des2016https://conductscience.org/library/papers/27262332PubMed
528095711Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice.J Enzyme Inhib Med Chem2017https://conductscience.org/library/papers/28095711PubMed
626610440Ursolic Acid--A Pentacyclic Triterpenoid with a Wide Spectrum of Pharmacological Activities.Molecules2015https://conductscience.org/library/papers/26610440PubMed
726341193Microenvironment acidity as a major determinant of tumor chemoresistance: Proton pump inhibitors (PPIs) as a novel therapeutic approach.Drug Resist Updat2015https://conductscience.org/library/papers/26341193PubMed
835428370Understanding of cell death induced by the constituents of Taxus yunnanensis wood.Sci Rep2022https://conductscience.org/library/papers/35428370PubMed
931467365Alkaliptosis: a new weapon for cancer therapy.Cancer Gene Ther2020https://conductscience.org/library/papers/31467365PubMed
1025305622Studies on the binding of fulvic acid with transferrin by spectroscopic analysis.Spectrochim Acta A Mol Biomol Spectrosc2015https://conductscience.org/library/papers/25305622PubMed
1129453373Dormancy release and germination of Taxus yunnanensis seeds during wet sand storage.Sci Rep2018https://conductscience.org/library/papers/29453373PubMed
1231590362Curcumin and Cancer.Nutrients2019https://conductscience.org/library/papers/31590362PubMed
1321376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
1427697635Apple pectin: A natural source for cancer suppression in 4T1 breast cancer cells in vitro and express p53 in mouse bearing 4T1 cancer tumors, in vivo.Biomed Pharmacother2016https://conductscience.org/library/papers/27697635PubMed
1511498364pH and drug resistance in tumors.Drug Resist Updat2000https://conductscience.org/library/papers/11498364PubMed
168847885Pharmacology of oleanolic acid and ursolic acid.J Ethnopharmacol1995https://conductscience.org/library/papers/8847885PubMed
179022122Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice.Cancer Lett1997https://conductscience.org/library/papers/9022122PubMed
1828912578Tumour acidosis: from the passenger to the driver's seat.Nat Rev Cancer2017https://conductscience.org/library/papers/28912578PubMed
198306331Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid.Cancer Res1994https://conductscience.org/library/papers/8306331PubMed
2030247761Higher diet-dependent acid load is associated with risk of breast cancer: Findings from the sister study.Int J Cancer2019https://conductscience.org/library/papers/30247761PubMed

See all 79 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/38931908

GET https://conductscience.org/api/papers/v1/38931908/references?page=2